Dercum’s Disease Market is a rare pain syndrome characterized by chronically painful growths of fatty tissue or lipomas. These lipomas most commonly occur in the upper arms, upper legs, and trunk region. According to a report by the American Society of Interventional Pain Physicians in 2017, although women are most commonly affected by this condition, about 16% of the reported cases were in men. The common symptoms of this condition include painful fatty lipomas covering the body, obesity majorly in women in menopausal age, weakness, memory issues, elevated heart rate, joint aches, depression, and dementia. Currently, there is no cure for this condition and it is treated symptomatically with surgery, alternative therapies, and with medications such as non-steroidal anti-inflammatory drugs, diuretics, among others.
The global dercum’s disease market is anticipated to be growing due to factors such increasing expenditures in the healthcare sector in the developed as well as developing economies, growing occurrences of lipomas, increasing prevalence of rare diseases, and rising research and development activities. On the other hand, lack of awareness about the disease is likely to hamper the growth of the market over the forecast period.
On the regional basis, the dercum’s disease market in the Americas is segmented into two major regions, i.e., North America and South America. The North American region is likely to hold the major share in the global dercum’s disease market, owing to the owing to the presence of a well-established healthcare segment, and increasing disposable income. Moreover, increasing funding for research and development by government fuels the market growth in this region.
The global dercum’s disease market has been segmented into treatment, distribution channel, and end user.
Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/6350
Pfizer, Inc., Abbvie, Inc., Johnson & Johnson, GlaxoSmithKline Plc, Merck & Co., Inc., Novartis, F. Hoffman, La Roche AG, Eli Lily and Company, AstraZeneca PLC, Amgen, Valeant Pharmaceuticals, Syneron Medical, St. Jude Medical Inc. and Alimed, Inc. are some major players in the global dercum’s disease market.
Akash Anand, Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India Phone: +1 646 845 9312 Email: firstname.lastname@example.org
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312